(5E)-5-(2,4-Dichlorobenzylidene)-2-(piperidin-1-yl)-1,3-thiazol-4(5H)-one
暂无分享,去创建一个
[1] R. Lesyk,et al. Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity. , 2009, European journal of medicinal chemistry.
[2] Anthony L. Spek,et al. Structure validation in chemical crystallography , 2009, Acta crystallographica. Section D, Biological crystallography.
[3] A. Dixit,et al. 2-Thiazolylimino/heteroarylimino-5-arylidene-4-thiazolidinones as new agents with SHP-2 inhibitory action. , 2008, Journal of medicinal chemistry.
[4] Hwangseo Park,et al. Discovery of novel PRL-3 inhibitors based on the structure-based virtual screening. , 2008, Bioorganic & medicinal chemistry letters.
[5] R. Lesyk,et al. New 5-substituted thiazolo[3,2-b][1,2,4]triazol-6-ones: synthesis and anticancer evaluation. , 2007, European journal of medicinal chemistry.
[6] Suk-Kyeong Jung,et al. Synthesis and biological evaluation of rhodanine derivatives as PRL-3 inhibitors. , 2006, Bioorganic & medicinal chemistry letters.
[7] R. Lesyk,et al. 4-Thiazolidones: Centenarian History, Current Status and Perspectives for Modern Organic and Medicinal Chemistry , 2004 .
[8] Raymond E. Davis,et al. Patterns in Hydrogen Bonding: Functionality and Graph Set Analysis in Crystals , 1995 .
[9] A. M. Glazer,et al. A nitrogen‐gas‐stream cryostat for general X‐ray diffraction studies , 1986 .
[10] D. Cremer,et al. General definition of ring puckering coordinates , 1975 .
[11] G. Sheldrick. A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.